These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24456201)
1. Ubiquitin-activating enzyme E1 inhibitor PYR41 attenuates angiotensin II-induced activation of dendritic cells via the IκBa/NF-κB and MKP1/ERK/STAT1 pathways. Chen C; Meng Y; Wang L; Wang HX; Tian C; Pang GD; Li HH; Du J Immunology; 2014 Jun; 142(2):307-19. PubMed ID: 24456201 [TBL] [Abstract][Full Text] [Related]
2. Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Yang Y; Kitagaki J; Dai RM; Tsai YC; Lorick KL; Ludwig RL; Pierre SA; Jensen JP; Davydov IV; Oberoi P; Li CC; Kenten JH; Beutler JA; Vousden KH; Weissman AM Cancer Res; 2007 Oct; 67(19):9472-81. PubMed ID: 17909057 [TBL] [Abstract][Full Text] [Related]
3. Administration of ubiquitin-activating enzyme UBA1 inhibitor PYR-41 attenuates angiotensin II-induced cardiac remodeling in mice. Shu Q; Lai S; Wang XM; Zhang YL; Yang XL; Bi HL; Li HH Biochem Biophys Res Commun; 2018 Oct; 505(1):317-324. PubMed ID: 30249396 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II Regulates Dendritic Cells through Activation of NF-κB /p65, ERK1/2 and STAT1 Pathways. Meng Y; Chen C; Liu Y; Tian C; Li HH Cell Physiol Biochem; 2017; 42(4):1550-1558. PubMed ID: 28723692 [TBL] [Abstract][Full Text] [Related]
5. The ubiquitin-activating enzyme E1 as a novel therapeutic target for the treatment of restenosis. Qin Z; Cui B; Jin J; Song M; Zhou B; Guo H; Qian D; He Y; Huang L Atherosclerosis; 2016 Apr; 247():142-53. PubMed ID: 26919560 [TBL] [Abstract][Full Text] [Related]
6. PPAR-gamma agonist inhibits Ang II-induced activation of dendritic cells via the MAPK and NF-kappaB pathways. Wei-guo Z; Hui Y; Shan L; Yun Z; Wen-cheng N; Fu-lin Y; Fang-yan F; Jun-hua G; Jian-hua Z Immunol Cell Biol; 2010; 88(3):305-12. PubMed ID: 19997078 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II Regulates Th1 T Cell Differentiation Through Angiotensin II Type 1 Receptor-PKA-Mediated Activation of Proteasome. Qin XY; Zhang YL; Chi YF; Yan B; Zeng XJ; Li HH; Liu Y Cell Physiol Biochem; 2018; 45(4):1366-1376. PubMed ID: 29462804 [TBL] [Abstract][Full Text] [Related]
8. Direct effects of polymyxin B on human dendritic cells maturation. The role of IkappaB-alpha/NF-kappaB and ERK1/2 pathways and adhesion. Valentinis B; Bianchi A; Zhou D; Cipponi A; Catalanotti F; Russo V; Traversari C J Biol Chem; 2005 Apr; 280(14):14264-71. PubMed ID: 15671028 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium. Tao L; Qiu Y; Fu X; Lin R; Lei C; Wang J; Lei B J Neuroinflammation; 2016 Feb; 13():35. PubMed ID: 26862037 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Ruiz-Ortega M; Lorenzo O; Rupérez M; König S; Wittig B; Egido J Circ Res; 2000 Jun; 86(12):1266-72. PubMed ID: 10864918 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin-(1-7) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-κB Pathways in HUVECs. Liang B; Wang X; Zhang N; Yang H; Bai R; Liu M; Bian Y; Xiao C; Yang Z Cell Physiol Biochem; 2015; 35(6):2472-82. PubMed ID: 25967876 [TBL] [Abstract][Full Text] [Related]
12. Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38. Xie J; Qian J; Wang S; Freeman ME; Epstein J; Yi Q J Immunol; 2003 Nov; 171(9):4792-800. PubMed ID: 14568957 [TBL] [Abstract][Full Text] [Related]
13. Insulin-Like Growth Factor 1 Receptor Deficiency Alleviates Angiotensin II-Induced Cardiac Fibrosis Through the Protein Kinase B/Extracellular Signal-Regulated Kinase/Nuclear Factor-κB Pathway. Zhu J; Li Q; Sun Y; Zhang S; Pan R; Xie Y; Chen J; Shi L; Chen Y; Sun Z; Zhang L J Am Heart Assoc; 2023 Sep; 12(18):e029631. PubMed ID: 37721135 [TBL] [Abstract][Full Text] [Related]
14. Lysyl-Transfer RNA Synthetase Induces the Maturation of Dendritic Cells through MAPK and NF-κB Pathways, Strongly Contributing to Enhanced Th1 Cell Responses. Lim HX; Jung HJ; Lee A; Park SH; Han BW; Cho D; Kim TS J Immunol; 2018 Nov; 201(9):2832-2841. PubMed ID: 30275047 [TBL] [Abstract][Full Text] [Related]
15. GPR174 suppression attenuates retinopathy in angiotensin II (Ang II)-treated mice by reducing inflammation via PI3K/AKT signaling. Yue J; Zhao X Biomed Pharmacother; 2020 Feb; 122():109701. PubMed ID: 31918274 [TBL] [Abstract][Full Text] [Related]
16. Distinct MAPK pathways are involved in IL-23 production in dendritic cells cocultured with NK cells in the absence or presence of angiotensin II. Yang L; Du C; Chen T; Li S; Nie W; Zhu W; Fan F; Zhu J; Yan H Mol Immunol; 2012 May; 51(1):51-6. PubMed ID: 22387269 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β1 modulates lipopolysaccharide-induced cytokine/chemokine production and inhibits nuclear factor-κB, extracellular signal-regulated kinases and p38 activation in dendritic cells in mice. Mou HB; Lin MF; Huang H; Cai Z Transplant Proc; 2011 Jun; 43(5):2049-52. PubMed ID: 21693323 [TBL] [Abstract][Full Text] [Related]
18. Fas ligation induces IL-1beta-dependent maturation and IL-1beta-independent survival of dendritic cells: different roles of ERK and NF-kappaB signaling pathways. Guo Z; Zhang M; An H; Chen W; Liu S; Guo J; Yu Y; Cao X Blood; 2003 Dec; 102(13):4441-7. PubMed ID: 12920043 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of ubiquitin-activating enzyme protects against organ injury after intestinal ischemia-reperfusion. Matsuo S; Chaung A; Liou D; Wang P; Yang WL Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G283-G292. PubMed ID: 29771572 [TBL] [Abstract][Full Text] [Related]